Security
RxSight, Inc. Common Stock · RXST
RXSTNASDAQCommon stockCurrentCIK 1111485Updated Oct 28, 2026
Name history
CALHOUN VISION INC · through Mar 20, 2014
RXST price & chart
Loading TradingView…
NASDAQ:RXST on TradingView ↗About the company
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL/LAL+, collectively the “LAL”), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
In the news
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules ↗
RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST News provided by DJS Law Group LLP Sep 22, 2025, 04:24 ET Share this article Share to X Share this article Share to X LOS ANGELES , Sept. 22, 2025 /PRNewswire/ -- The DJS Law Group ↗
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm News provided by The Schall Law Firm Sep 22, 2025, 03:38 ET Share this article Share to X Share this article Share to X LOS ANGELES , Sept. 22, 2025 /PRNewswire/ -- The Schall Law Firm , a nationa ↗
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 308,533,000Source | 310,469,000Source | 352,700,000Source | 309,009,000Source | 305,499,000Source | 303,993,000Source | 313,044,000Source | 183,165,000Source | 311,814,000Source | 318,563,000Source | 182,550,000Source | 150,164,000Source |
| Property, Plant and Equipment, NetUSD | 13,096,000Source | 12,241,000Source | 14,039,000Source | 13,255,000Source | 12,444,000Source | 13,232,000Source | 12,557,000Source | 11,617,000Source | 13,056,000Source | 12,413,000Source | 10,841,000Source | 10,138,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 29,633,000Source | 16,720,000Source | 13,352,000Source | 40,355,000Source | 24,445,000Source | 17,573,000Source | 28,000,000Source | 32,645,000Source | 19,949,000Source | 16,706,000Source | 9,692,000Source | 11,834,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 24,151,000Source | 25,368,000Source | 18,519,000Source | 28,058,000Source | 25,723,000Source | 22,443,000Source | 30,958,000Source | 21,550,000Source | 23,383,000Source | 30,050,000Source | 20,281,000Source | 10,956,000Source |
| Inventory, NetUSD | 28,950,000Source | 21,673,000Source | 37,117,000Source | 25,061,000Source | 19,443,000Source | 34,869,000Source | 23,574,000Source | 18,700,000Source | 31,559,000Source | 22,009,000Source | 17,421,000Source | 14,835,000Source |
| Assets, CurrentUSD | 283,877,000Source | 286,768,000Source | 327,396,000Source | 283,874,000Source | 281,223,000Source | 279,225,000Source | 288,414,000Source | 168,559,000Source | 287,459,000Source | 293,823,000Source | 168,407,000Source | 134,555,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,260,000Source | 2,607,000Source | 2,961,000Source | 3,264,000Source | 2,773,000Source | 4,033,000Source | 4,541,000Source | 2,955,000Source | 4,389,000Source | 4,541,000Source | 3,523,000Source | 2,962,000Source |
| Operating Lease, Right-of-Use AssetUSD | 10,276,000Source | 10,536,000Source | 9,491,000Source | 10,588,000Source | 10,818,000Source | 9,760,000Source | 10,922,000Source | 2,052,000Source | 9,959,000Source | 11,217,000Source | 2,444,000Source | 3,943,000Source |
| Other Assets, NoncurrentUSD | 536,000Source | 213,000Source | 1,024,000Source | 542,000Source | 303,000Source | 1,026,000Source | 401,000Source | 226,000Source | 590,000Source | 360,000Source | 147,000Source | 767,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 32,563,000Source | 33,208,000Source | 89,360,000Source | 30,997,000Source | 30,292,000Source | 36,698,000Source | 33,728,000Source | 19,236,000Source | 36,131,000Source | 37,325,000Source | 22,188,000Source | 60,262,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 41,000Source | 40,000Source | 41,000Source | 41,000Source | 40,000Source | 41,000Source | 41,000Source | 37,000Source | 41,000Source | 40,000Source | 36,000Source | 28,000Source |
| Additional Paid in CapitalUSD | 927,756,000Source | 892,857,000Source | 952,378,000Source | 920,159,000Source | 885,104,000Source | 944,244,000Source | 909,545,000Source | 767,685,000Source | 936,628,000Source | 903,127,000Source | 754,971,000Source | 636,001,000Source |
| Retained Earnings (Accumulated Deficit)USD | -651,887,000Source | -616,157,000Source | -689,020,000Source | -642,071,000Source | -609,819,000Source | -676,923,000Source | -630,285,000Source | -603,740,000Source | -661,039,000Source | -622,095,000Source | -594,640,000Source | -546,032,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 60,000Source | 521,000Source | -59,000Source | -117,000Source | -118,000Source | -67,000Source | 15,000Source | -53,000Source | 53,000Source | 166,000Source | -5,000Source | -95,000Source |
| Stockholders' Equity Attributable to ParentUSD | 275,970,000Source | 277,261,000Source | 263,340,000Source | 278,012,000Source | 275,207,000Source | 267,295,000Source | 279,316,000Source | 163,929,000Source | 275,683,000Source | 281,238,000Source | 160,362,000Source | 89,902,000Source |
| Liabilities and EquityUSD | 308,533,000Source | 310,469,000Source | 352,700,000Source | 309,009,000Source | 305,499,000Source | 303,993,000Source | 313,044,000Source | 183,165,000Source | 311,814,000Source | 318,563,000Source | 182,550,000Source | 150,164,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 22,291,000Source | 22,638,000Source | 80,444,000Source | 20,383,000Source | 19,618,000Source | 27,376,000Source | 22,741,000Source | 18,328,000Source | 26,253,000Source | 25,876,000Source | 20,903,000Source | 17,237,000Source |
| Operating Lease, Liability, CurrentUSD | 1,265,000Source | 707,000Source | 1,633,000Source | 1,075,000Source | 710,000Source | 1,474,000Source | 1,023,000Source | 1,590,000Source | 1,134,000Source | 946,000Source | 1,764,000Source | 1,818,000Source |
| Accounts Payable, CurrentUSD | 3,377,000Source | 4,581,000Source | 6,345,000Source | 3,348,000Source | 5,095,000Source | 7,124,000Source | 7,111,000Source | 5,057,000Source | 5,296,000Source | 4,544,000Source | 3,863,000Source | 2,595,000Source |
| Operating Lease, Liability, NoncurrentUSD | 10,200,000Source | 10,456,000Source | 8,867,000Source | 10,534,000Source | 10,553,000Source | 9,265,000Source | 10,879,000Source | 788,000Source | 9,813,000Source | 11,216,000Source | 1,093,000Source | 2,813,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | 19,795,000Source | 20,358,000Source | 15,239,000Source | 12,672,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 227,500,000Source | 237,100,000Source | 208,800,000Source | 227,500,000Source | 233,200,000Source | 217,900,000Source | 229,300,000Source | 125,400,000Source | 228,100,000Source | 237,200,000Source | 127,200,000Source | 105,800,000Source |
| Long-term DebtUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 40,169,000Source |
| Short-term InvestmentsUSD | 197,883,000Source | 220,400,000Source | 195,447,000Source | 187,136,000Source | 208,839,000Source | 200,307,000Source | 201,341,000Source | 92,709,000Source | 208,179,000Source | 220,517,000Source | 117,490,000Source | 93,968,000Source |
| Deferred Revenue, Current | — | — | —Source | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -15,884,000Source | -8,190,000Source | -38,944,000Source | -27,455,000Source | -48,608,000Source | -66,756,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 834,000Source | 776,000Source | 3,266,000Source | 3,575,000Source | 4,078,000Source | 3,884,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 7,945,000Source | 7,140,000Source | 31,612,000Source | 24,635,000Source | 15,746,000Source | 11,397,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -936,000Source | 928,000Source | -6,655,000Source | 9,803,000Source | 9,325,000Source | 6,094,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 3,370,000Source | 1,597,000Source | 11,482,000Source | 4,993,000Source | 2,749,000Source | 7,555,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 1,577,000Source | 2,226,000Source | 627,000Source | 946,000Source | 1,250,000Source | 635,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 6,541,000Source | 19,101,000Source | -12,793,000Source | -14,908,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -10,891,000Source | -8,832,000Source | -15,511,000Source | -16,946,000Source | -41,593,000Source | -58,850,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 8,848,000Source | 20,855,000Source | 16,889,000Source | -99,311,000Source | -22,129,000Source | 39,950,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 759,000Source | 575,000Source | 3,830,000Source | 5,440,000Source | 4,814,000Source | 2,393,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -336,000Source | -735,000Source | 1,863,000Source | 123,319,000Source | 61,524,000Source | 6,332,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -2,376,000Source | 11,294,000Source | 3,243,000Source | 7,053,000Source | -2,192,000Source | -12,577,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 30,382,000Source | 17,431,000Source | 14,102,000Source | 41,105,000Source | 18,323,000Source | 28,750,000Source | 20,699,000Source | 17,456,000Source | 10,403,000Source | 12,595,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 0Source | 3,000Source | 58,000Source | 24,000Source | 8,000Source | 3,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 3,000Source | 6,000Source | 3,000Source | -9,000Source | 6,000Source | -9,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 287,000Source | 552,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 227,500,000Source | 237,100,000Source | 208,800,000Source | 227,500,000Source | 217,900,000Source | 229,300,000Source | 228,100,000Source | 237,200,000Source | 127,200,000Source | 105,800,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | -1,769,000Source | — |
| Income Tax Expense (Benefit)USD | — | — | 10,000Source | 13,000Source | 88,000Source | 32,000Source | 6,000Source | 18,000Source | 66,000Source | 50,000Source | 20,000Source | 9,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | 60,000Source | 31,000Source | 1,932,000Source | 404,000Source | 164,000Source | 752,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -9,816,000Source | -6,338,000Source | -12,097,000Source | -11,786,000Source | -15,884,000Source | -8,190,000Source | -38,944,000Source | -27,455,000Source | -48,608,000Source | -66,756,000Source |
| Operating ExpensesUSD | — | — | 36,405,000Source | 34,446,000Source | 47,511,000Source | 47,640,000Source | 41,327,000Source | 39,003,000Source | 151,200,000Source | 135,801,000Source | 103,850,000Source | 84,646,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 144,000Source | 696,000Source | 3,951,000Source | 20,816,000Source | 9,473,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | 65,000Source | 33,000Source | 53,000Source | 190,000Source | 10,000Source | 75,000Source |
| Operating Costs and Expenses | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 30,340,000Source | 35,314,000Source | 27,241,000Source | 33,637,000Source | 30,893,000Source | 37,895,000Source | 134,479,000Source | 139,927,000Source | 89,077,000Source | 49,005,000Source |
| Cost of RevenueUSD | — | — | 6,113,000Source | 10,094,000Source | 7,855,000Source | 8,447,000Source | 7,395,000Source | 9,566,000Source | 31,470,000Source | 40,984,000Source | 35,312,000Source | 27,677,000Source |
| Selling, General and Administrative ExpenseUSD | — | — | 27,345,000Source | 25,608,000Source | 30,419,000Source | 28,976,000Source | 31,855,000Source | 28,636,000Source | 112,651,000Source | 101,434,000Source | 74,799,000Source | 58,665,000Source |
| Operating Income (Loss)USD | — | — | -12,178,000Source | -9,226,000Source | -13,770,000Source | -14,003,000Source | -17,829,000Source | -10,674,000Source | -48,191,000Source | -36,858,000Source | -50,085,000Source | -63,318,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -9,806,000Source | -6,325,000Source | -12,009,000Source | -11,754,000Source | -15,878,000Source | -8,172,000Source | -38,878,000Source | -27,405,000Source | -48,588,000Source | -66,747,000Source |
| Income Tax Expense (Benefit)USD | — | — | 10,000Source | 13,000Source | 88,000Source | 32,000Source | 6,000Source | 18,000Source | 66,000Source | 50,000Source | 20,000Source | 9,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -9,816,000Source | -6,338,000Source | -12,097,000Source | -11,786,000Source | -15,884,000Source | -8,190,000Source | -38,944,000Source | -27,455,000Source | -48,608,000Source | -66,756,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.24Source | -0.16Source | -0.29Source | -0.29Source | -0.38Source | -0.2Source | -0.95Source | -0.71Source | -1.41Source | -2.41Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.24Source | -0.16Source | -0.29Source | -0.29Source | -0.38Source | -0.2Source | -0.95Source | -0.71Source | -1.41Source | -2.41Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 40,965,219Source | 39,788,621Source | 41,490,889Source | 40,743,786Source | 41,306,110Source | 40,509,646Source | 40,850,739Source | 38,867,726Source | 34,455,111Source | 27,661,982Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 40,965,219Source | 39,788,621Source | 41,490,889Source | 40,743,786Source | 41,306,110Source | 40,509,646Source | 40,850,739Source | 38,867,726Source | 34,455,111Source | 27,661,982Source |
| Additional Financial Items | ||||||||||||
| Cost, Depreciation and AmortizationUSD | — | — | — | — | — | — | — | — | 3,300,000Source | 3,600,000Source | 4,100,000Source | 3,900,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 66,000Source | 50,000Source | 20,000Source | 9,000Source |
| Gross ProfitUSD | — | — | 24,227,000Source | 25,220,000Source | — | 25,190,000Source | 23,498,000Source | 28,329,000Source | 103,009,000Source | 98,943,000Source | 53,765,000Source | 21,328,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -38,877,000Source | -27,406,000Source | -48,590,000Source | -66,750,000Source |
| Interest and Other IncomeUSD | — | — | 2,376,000Source | 2,906,000Source | 1,764,000Source | 2,254,000Source | 1,954,000Source | 2,508,000Source | 9,332,000Source | 9,474,000Source | 6,574,000Source | 1,517,000Source |
| Interest ExpenseUSD | — | — | 4,000Source | 5,000Source | 3,000Source | 5,000Source | 3,000Source | 6,000Source | 19,000Source | 21,000Source | 3,308,000Source | 4,946,000Source |
| Operating ExpensesUSD | — | — | 36,405,000Source | 34,446,000Source | 47,511,000Source | 47,640,000Source | 41,327,000Source | 39,003,000Source | 151,200,000Source | 135,801,000Source | 103,850,000Source | 84,646,000Source |
| Research and Development ExpenseUSD | — | — | 9,060,000Source | 8,838,000Source | 9,237,000Source | 10,217,000Source | 9,472,000Source | 10,367,000Source | 38,549,000Source | 34,367,000Source | 29,051,000Source | 25,981,000Source |
| Costs and Expenses | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Operating Costs and Expenses | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Revenue from Contract with Customer, Including Assessed Tax | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Offerings
Registration 333-279206
Filing attachments
rxst-ex99_1.htm · 8-K · 2026-08-05
EX-99.1 2 rxst-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 RXSIGHT, INC. REPORTS SECOND QUARTER 2026 RESULTS AND PROVIDES UPDATE ON 2026 OUTLOOK Aliso Viejo, Calif. - August 5, 2026 - RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended June 30, 2026, and provided an update on its 2026 financial outlook. Second Quarter 2026 Highlights • Total company Q2 revenue of $33.7 million, which includes $6.5 million in revenue recognized from the RxSight Alcon strategic…
Read attachment ↗d135524dex42.htm · S-8 · 2026-07-23
Exhibit 4.2 RxSIGHT, INC. 2026 INDUCEMENT EQUITY INCENTIVE PLAN 1. Purposes of the Plan; Award Types. (a) Purposes of the Plan. The purposes of this Plan are to attract and retain the best available personnel for positions of substantial responsibility by providing an inducement material to individuals entering into employment with the Company Group. (b) Award Types. The Plan permits the grant of Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units…
Read attachment ↗d135524dex43.htm · S-8 · 2026-07-23
Exhibit 4.3 RxSIGHT, INC. 2026 INDUCEMENT EQUITY INCENTIVE PLAN NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AGREEMENT Capitalized terms that are not defined in this Notice of Stock Option Grant and Stock Option Agreement (the “Notice of Grant”), the Terms and Conditions of Stock Option Grant, the Non-U.S. Appendix attached hereto as Exhibit B and all other exhibits to these documents (all together, the “Agreement”) have the meanings given to them in the RxSight, Inc. 2026 Inducement Equity…
Read attachment ↗d135524dex44.htm · S-8 · 2026-07-23
Exhibit 4.4 RxSIGHT, INC. 2026 INDUCEMENT EQUITY INCENTIVE PLAN NOTICE OF RESTRICTED STOCK UNIT AWARD AND RESTRICTED STOCK UNIT AGREEMENT Capitalized terms that are not defined in this Notice of Restricted Stock Unit Award and Restricted Stock Unit Agreement (the “Notice of Grant”), the Terms and Conditions of Restricted Stock Unit Award, the Non-U.S. Appendix attached hereto as Exhibit B and all other exhibits to these documents (all together, the “Agreement”) have the meanings given to th…
Read attachment ↗d140030dex991.htm · 8-K · 2026-07-15
EX-99.1 2 d140030dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 RXSIGHT ANNOUNCES APPOINTMENTS OF AZIZ MOTTIWALA AS CHIEF EXECUTIVE OFFICER AND RON KURTZ, MD AS CHIEF MEDICAL OFFICER Aliso Viejo, Calif. - July 15, 2026 - RxSight, Inc. (NASDAQ: RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive Officer, succeeding Ron Kurtz, M.D., who will continue to serve as Chief Medical Officer. Mr. Mottiwala brings exten…
Read attachment ↗rxst-ex99_1.htm · 8-K · 2026-07-06
EX-99.1 2 rxst-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs • Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies • Collaboration aims to combine best-in-class PCIOL optics with first-in-class platform to enable fine-tuning of visual outcomes after cataract surgery Aliso Viejo, CA, July 6th, 2026 - Alcon (SIX/NYSE: ALC), the global leader in …
Read attachment ↗